Story Poster
Photo by Twitter / Cal Men's Basketball
Cal Basketball

Cal Defeated By Clemson At Emerald Coast Classic

November 26, 2022
615

NICEVILLE, Fla. (AP) – Three Golden Bears scored in double figures as California fell short in a 67-59 loss to Clemson in the third-place game at the Emerald Coast Classic on Saturday afternoon.

The Tigers (5-2) rebounded from a 74-71 loss to No. 25 Iowa on Friday that ended a three-game win streak and were paced by 14 points from both Chase Hunter and Hunter Tyson. Cal remained winless on the season, dropping to 0-7.

Hunter was 5 of 10 from the floor and had seven assists. Tyson was 4-of-8 shooting and grabbed five rebounds. The pair combined for five of the Tigers’ seven 3-pointers. Brevin Galloway added 13 points and PJ Hall had 10 for Clemson, which shot 53.5 percent (23 of 43) from the field.

Devin Askew led Cal with 18 points while Lars Thiemann added 15 points on 6-of-7 shooting to go along with five rebounds and three blocks. Kuany Kuany chipped in 11 points, scoring in double figures for the first time in four games.

Clemson never trailed and led 31-28 at halftime. The Tigers opened the second half on a 15-2 run for a 46-30 lead with 14:15 to play. Hunter and Tyson each scored five points with a 3-pointer during the stretch. Cal cut the deficit to 63-57 with 30 seconds left on a fast-break layup by Askew, but didn’t get closer.

The Bears’ free-throw shooting kept them close, as they made 18 of 20 attempts at the charity stripe with Kuany (7 of 8) and Askew (6 of 7) highlighting the effort. Cal shot just 39.6 percent (19 of 48) from the floor and 15 percent (3 of 20) from deep in the loss.

UP NEXT

Cal hosts USC on Wednesday, Nov. 30 in its first of two early Pac-12 Conference contests. Tipoff is set for 7 p.m. PT inside of Haas Pavilion in Berkeley and the game will be televised on the Pac-12 Network.

Related:

Cal Downed By TCU At Emerald Coast Classic

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.